Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial

Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label was updated from Revision: v3.5.4 to Revision: v3.5.5. This indicates the page has been refreshed to a newer release without changing the primary content shown to users.
    Difference
    0.0%
    Check dated 2026-06-06T19:10:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The record revision label was updated from v3.5.3 to v3.5.4, signaling a newer version of the ClinicalTrials.gov page.
    Difference
    0.0%
    Check dated 2026-05-16T08:33:34.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page reflects an administrative refresh of the study listing: the record/revision version updated (v3.5.2 → v3.5.3) along with updated posted/last-update dates. It also shows the Barcelona location details adjusted at a more specific formatting level (e.g., how the address is displayed), without changing the overall study location being listed or its main protocol elements.
    Difference
    1%
    Check dated 2026-04-25T05:14:32.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. This appears to be a minor version update with no user-facing content changes.
    Difference
    0.0%
    Check dated 2026-04-17T22:49:06.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added the MeSH term 'Mucopolysaccharidosis, MPS-III-A' to the study record.
    Difference
    0.0%
    Check dated 2026-04-02T15:22:02.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a screening threshold: Cohorts 1-3 require anti-AAV9 antibody titers ≥ 1:100 (ELISA) to be considered positive. The previous screening criterion for Cohort 4 antibody positivity at screening has been removed.
    Difference
    0.2%
    Check dated 2026-03-26T11:23:48.000Z thumbnail image

Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.